2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide

C143H196N30O16S6 — CID 158812427

About 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide

2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide (PubChem CID 158812427) has the molecular formula C143H196N30O16S6 and a molecular weight of 2783.74 g/mol. Its IUPAC name is 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide.

Molecular Properties

• Compound Name: 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide
• PubChem CID: 158812427
• Molecular Formula: C143H196N30O16S6
• Molecular Weight: 2783.74 g/mol
• Exact Mass: 2781.38
• IUPAC Name: 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide
• SMILES: C.C.C.C.C=C(NC(C)c1cn(C)nc1C)c1cccc(C2CCN(c3nc4c(c(NC5CCOCC5)n3)S(=O)CC4)CC2)c1.CC(C)(NC(=O)c1cccc(C2CCN(c3nc4c(c(NC5CCOCC5)n3)S(=O)CC4)CC2)c1)c1ccncc1.CN1C[C@@H](Nc2nc(N3CCC(C(=O)N4CCOCC4)(c4ccccc4)CC3)nc3c2S(=O)CC3)CCC1=O.CN1C[C@@H](Nc2nc(N3CCC(CNS(C)(=O)=O)(c4ccccc4)CC3)nc3c2S(=O)CC3)CCC1=O.Cc1ccc(C2(O)CCN(c3nc4c(c(N[C@H]5CCC(=O)N(C)C5)n3)S(=O)CC4)CC2)cc1
• InChI: InChI=1S/C31H41N7O2S.C31H38N6O3S.C28H36N6O4S.C25H34N6O4S2.C24H31N5O3S.4CH4/c1-20(32-21(2)27-19-37(4)36-22(27)3)24-6-5-7-25(18-24)23-8-13-38(14-9-23)31-34-28-12-17-41(39)29(28)30(35-31)33-26-10-15-40-16-11-26;1-31(2,24-6-13-32-14-7-24)36-29(38)23-5-3-4-22(20-23)21-8-15-37(16-9-21)30-34-26-12-19-41(39)27(26)28(35-30)33-25-10-17-40-18-11-25;1-32-19-21(7-8-23(32)35)29-25-24-22(9-18-39(24)37)30-27(31-25)34-12-10-28(11-13-34,20-5-3-2-4-6-20)26(36)33-14-16-38-17-15-33;1-30-16-19(8-9-21(30)32)27-23-22-20(10-15-36(22)33)28-24(29-23)31-13-11-25(12-14-31,17-26-37(2,34)35)18-6-4-3-5-7-18;1-16-3-5-17(6-4-16)24(31)10-12-29(13-11-24)23-26-19-9-14-33(32)21(19)22(27-23)25-18-7-8-20(30)28(2)15-18;;;;/h5-7,18-19,21,23,26,32H,1,8-17H2,2-4H3,(H,33,34,35);3-7,13-14,20-21,25H,8-12,15-19H2,1-2H3,(H,36,38)(H,33,34,35);2-6,21H,7-19H2,1H3,(H,29,30,31);3-7,19,26H,8-17H2,1-2H3,(H,27,28,29);3-6,18,31H,7-15H2,1-2H3,(H,25,26,27);4*1H4/t;;21-,39?;19-,36?;18-,33?;;;;/m..000..../s1
• InChIKey: IUVWEZUIQCXFKA-PQTFGKGJSA-N
• XLogP: 16.00
• TPSA: 537.77 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 40
• Rotatable Bonds: 31
• Heavy Atoms: 195
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2783.74
LogP ≤ 5	16.00
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	40

Frequently Asked Questions

What is the IUPAC name of 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide?

The IUPAC name of 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide (CID 158812427) is 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide.

What is the SMILES notation for 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide?

The canonical SMILES for 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide is C.C.C.C.C=C(NC(C)c1cn(C)nc1C)c1cccc(C2CCN(c3nc4c(c(NC5CCOCC5)n3)S(=O)CC4)CC2)c1.CC(C)(NC(=O)c1cccc(C2CCN(c3nc4c(c(NC5CCOCC5)n3)S(=O)CC4)CC2)c1)c1ccncc1.CN1C[C@@H](Nc2nc(N3CCC(C(=O)N4CCOCC4)(c4ccccc4)CC3)nc3c2S(=O)CC3)CCC1=O.CN1C[C@@H](Nc2nc(N3CCC(CNS(C)(=O)=O)(c4ccccc4)CC3)nc3c2S(=O)CC3)CCC1=O.Cc1ccc(C2(O)CCN(c3nc4c(c(N[C@H]5CCC(=O)N(C)C5)n3)S(=O)CC4)CC2)cc1.

What is the InChIKey of 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide?

The InChIKey is IUVWEZUIQCXFKA-PQTFGKGJSA-N. The full InChI is InChI=1S/C31H41N7O2S.C31H38N6O3S.C28H36N6O4S.C25H34N6O4S2.C24H31N5O3S.4CH4/c1-20(32-21(2)27-19-37(4)36-22(27)3)24-6-5-7-25(18-24)23-8-13-38(14-9-23)31-34-28-12-17-41(39)29(28)30(35-31)33-26-10-15-40-16-11-26;1-31(2,24-6-13-32-14-7-24)36-29(38)23-5-3-4-22(20-23)21-8-15-37(16-9-21)30-34-26-12-19-41(39)27(26)28(35-30)33-25-10-17-40-18-11-25;1-32-19-21(7-8-23(32)35)29-25-24-22(9-18-39(24)37)30-27(31-25)34-12-10-28(11-13-34,20-5-3-2-4-6-20)26(36)33-14-16-38-17-15-33;1-30-16-19(8-9-21(30)32)27-23-22-20(10-15-36(22)33)28-24(29-23)31-13-11-25(12-14-31,17-26-37(2,34)35)18-6-4-3-5-7-18;1-16-3-5-17(6-4-16)24(31)10-12-29(13-11-24)23-26-19-9-14-33(32)21(19)22(27-23)25-18-7-8-20(30)28(2)15-18;;;;/h5-7,18-19,21,23,26,32H,1,8-17H2,2-4H3,(H,33,34,35);3-7,13-14,20-21,25H,8-12,15-19H2,1-2H3,(H,36,38)(H,33,34,35);2-6,21H,7-19H2,1H3,(H,29,30,31);3-7,19,26H,8-17H2,1-2H3,(H,27,28,29);3-6,18,31H,7-15H2,1-2H3,(H,25,26,27);4*1H4/t;;21-,39?;19-,36?;18-,33?;;;;/m..000..../s1.

What are the key properties of 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide?

2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide has a molecular weight of 2783.74 g/mol, XLogP of 16.00, 31 rotatable bonds, 9 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4-[3-[1-[1-(1,3-dimethylpyrazol-4-yl)ethylamino]ethenyl]phenyl]piperidin-1-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine;(5S)-5-[[2-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]-1-methylpiperidin-2-one;methane;(5S)-1-methyl-5-[[2-[4-(morpholine-4-carbonyl)-4-phenylpiperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]piperidin-2-one;N-[[1-[4-[[(3S)-1-methyl-6-oxopiperidin-3-yl]amino]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]-4-phenylpiperidin-4-yl]methyl]methanesulfonamide;3-[1-[4-(oxan-4-ylamino)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]piperidin-4-yl]-N-(2-pyridin-4-ylpropan-2-yl)benzamide is sourced from PubChem (CID 158812427), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).